# Belimumab

## Benlysta inj 400mg

| 藥物代碼           | IBEN                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Reducing disease activity in adult patients with active autoantibody positive SLE receiving standard therapy.                                                                                                                                                                                                                                                                                                                        |
| 副作用             | Infections. Hypersensitivity reaction; pyrexia, infusion-related reaction.                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌               | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 用法用量           | Adult 10 mg/kg IV infusion over 1 hour on days 0, 14 & 28 and at 4 week intervals thereafter.                                                                                                                                                                                                                                                                                                                                        |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 孕期用藥建議       | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 乾粉稀釋液         | IVD: 4.8mL D/W                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 輸注點滴液         | 【H/S】 可選 仿單建議  【L/R】 可選 仿單建議  【N/S】 可選 仿單建議                                                                                                                                                                                                                                                                                                                                                                  |
| IVP 用法建議       | X                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IVD 用法建議       | Benlysta should be infused in 250mL infusion solution over a 1 hour period.                                                                                                                                                                                                                                                                                                                                                          |
| 注意事項           | 1. The total time from reconstitution of Benlysta to completion of infusion should not exceed 8 hours. 2. Benlysta should not be infused concomitantly in the same IV line with other agents. 3.The 400-mg single-use vial of Benlysta should be reconstituted with 4.8 mL of sterile water for injections to yield a final concentration of belimumab 80 mg/mL. 4.Do not shake. 5.Protect the reconstituted solution from sunlight. |

